NASDAQ:BRKR - Bruker Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $30.19 +0.47 (+1.58 %) (As of 07/22/2018 08:56 AM ET)Previous Close$30.19Today's Range$29.56 - $30.3252-Week Range$26.98 - $36.53Volume995,021 shsAverage Volume564,984 shsMarket Capitalization$4.71 billionP/E Ratio24.95Dividend Yield0.53%Beta1.17 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts. Receive BRKR News and Ratings via Email Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology SymbolNASDAQ:BRKR CUSIP11679410 Webwww.bruker.com Phone978-663-3660 Debt Debt-to-Equity Ratio0.26 Current Ratio2.22 Quick Ratio1.29 Price-To-Earnings Trailing P/E Ratio24.95 Forward P/E Ratio21.88 P/E Growth1.94 Sales & Book Value Annual Sales$1.77 billion Price / Sales2.67 Cash Flow$1.6479 per share Price / Cash18.32 Book Value$4.72 per share Price / Book6.40 Profitability EPS (Most Recent Fiscal Year)$1.21 Net Income$78.60 million Net Margins4.63% Return on Equity27.04% Return on Assets10.69% Miscellaneous Employees6,200 Outstanding Shares156,080,000Market Cap$4,712.12 Bruker (NASDAQ:BRKR) Frequently Asked Questions What is Bruker's stock symbol? Bruker trades on the NASDAQ under the ticker symbol "BRKR." How often does Bruker pay dividends? What is the dividend yield for Bruker? Bruker announced a quarterly dividend on Tuesday, May 15th. Stockholders of record on Monday, June 4th will be given a dividend of $0.04 per share on Friday, June 22nd. This represents a $0.16 annualized dividend and a dividend yield of 0.53%. The ex-dividend date is Friday, June 1st. View Bruker's Dividend History. How will Bruker's stock buyback program work? Bruker declared that its board has initiated a share buyback plan on Sunday, June 4th 2017, which allows the company to buyback $225,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company's management believes its stock is undervalued. How were Bruker's earnings last quarter? Bruker Co. (NASDAQ:BRKR) released its quarterly earnings results on Thursday, May, 3rd. The medical research company reported $0.24 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.22 by $0.02. The medical research company had revenue of $431.70 million for the quarter, compared to analyst estimates of $419.25 million. Bruker had a return on equity of 27.04% and a net margin of 4.63%. Bruker's revenue was up 12.2% compared to the same quarter last year. During the same period last year, the firm posted $0.19 EPS. View Bruker's Earnings History. When is Bruker's next earnings date? Bruker is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Bruker. What price target have analysts set for BRKR? 9 equities research analysts have issued 1 year target prices for Bruker's stock. Their forecasts range from $24.00 to $42.00. On average, they expect Bruker's share price to reach $32.8889 in the next year. This suggests a possible upside of 8.9% from the stock's current price. View Analyst Ratings for Bruker. What is the consensus analysts' recommendation for Bruker? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." Who are some of Bruker's key competitors? Some companies that are related to Bruker include Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), PerkinElmer (PKI), Bio-Rad Laboratories, Inc. Class B (BIO.B), Integra Lifesciences (IART), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Eyepoint Pharmaceuticals (EYPT) and HTG Molecular Diagnostics (HTGM). Who are Bruker's key executives? Bruker's management team includes the folowing people: Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 56)Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 63)Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 60)Stacey Desrochers, Treasurer & Director of Investor Relations Has Bruker been receiving favorable news coverage? News headlines about BRKR stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bruker earned a media sentiment score of 0.18 on Accern's scale. They also gave press coverage about the medical research company an impact score of 45.92 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future. Who are Bruker's major shareholders? Bruker's stock is owned by a number of of institutional and retail investors. Top institutional investors include Scout Investments Inc. (0.12%), Cambiar Investors LLC (0.10%), Thompson Rubinstein Investment Management Inc. OR (0.09%), Fisher Asset Management LLC (0.09%), Clinton Group Inc. (0.03%) and Fox Run Management L.L.C. (0.02%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch, Richard A Packer and Richard Kniss. View Institutional Ownership Trends for Bruker. Which institutional investors are selling Bruker stock? BRKR stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Fisher Asset Management LLC and Scout Investments Inc.. View Insider Buying and Selling for Bruker. Which institutional investors are buying Bruker stock? BRKR stock was purchased by a variety of institutional investors in the last quarter, including Clinton Group Inc., Cornerstone Wealth Management LLC, Fox Run Management L.L.C., Thompson Rubinstein Investment Management Inc. OR and State of Alaska Department of Revenue. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker. How do I buy shares of Bruker? Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bruker's stock price today? One share of BRKR stock can currently be purchased for approximately $30.19. How big of a company is Bruker? Bruker has a market capitalization of $4.71 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe. How can I contact Bruker? Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected] MarketBeat Community Rating for Bruker (NASDAQ BRKR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 477 (Vote Outperform)Underperform Votes: 529 (Vote Underperform)Total Votes: 1,006MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What kind of dividend yield to CEF's pay?